The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca ...

In turn, while the overall impact from them is still yet to be seen, Mr Bailey says tightening rates further could be more ...

Suggestions that AstraZeneca might cross the Atlantic should act as a huge wake-up call.

AstraZeneca’s chief executive has discussed quitting Britain in a move that would deal a significant blow to the City of ...

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.

It comes amid reports that the drugs maker is considering moving its listing from the UK to the US in what would be a hammer ...

AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the ...

The boss of Britain’s most valuable company, Astrazeneca, has reportedly voiced his preference to move the firm’s stock ...

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...

It was already a bad enough week for the Prime Minister Sir Keir Starmer and the Chancellor Rachel Reeves, what with the ...

Sky's James Sillars writes that a government, struggling for authority and prioritising economic growth, can not afford to ...